2022 HCPCS Codes > M Codes >
M1003
Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic disease modifying anti-rheumatic drug therapy for ra
- 2021 Status Change: Add procedure or modifier code
- Effective Date: 2019-01-01
- Medicare Coverage Status: Carrier Judgement
- BETOS Classification: Undefined codes
Medicare has not assigned a fee schedule for this code

